Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

DARK SECRETS: Neuronetics s return on capital employed insights - The Real Truth

According to data from Benzinga Pro, during Q4, Neuronetics's (NASDAQ:STIM) reported sales totaled $15.02 million. Despite a 6.32% increase in earnings, the company posted a loss of $7.64 million. In Q3, Neuronetics brought in $13.80 million in sales but lost $8.15 million in earnings.

What Is ROCE?

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.